Clinical trials
Recruiting Schizophrenia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
150 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 4 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 8 |
| 2021 | 6 |
| 2022 | 15 |
| 2023 | 25 |
| 2024 | 24 |
| 2025 | 38 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 150 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Mental Health Center | 6 |
| The University of Texas Health Science Center, Houston | 5 |
| VA Office of Research and Development | 5 |
| Central South University | 4 |
| Centre Hospitalier St Anne | 4 |
| Centre Hospitalier Universitaire de Saint Etienne | 3 |
| Centre Psychothérapique de Nancy | 3 |
| Hôpital le Vinatier | 3 |
| Massachusetts General Hospital | 3 |
| Mclean Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 150 |
| Psychotic Disorders | 55 |
| Bipolar Disorder | 27 |
| Hallucinations | 10 |
| Mental Disorders | 10 |
| Cognitive Dysfunction | 8 |
| Major Depressive Disorder | 8 |
| Schizophrenia, Treatment-Resistant | 4 |
| Stress Disorders, Post-Traumatic | 4 |
| Attention Deficit Disorder with Hyperactivity | 3 |
Trials
Showing 1 to 25 of 150. Each trial links to its page on Pharma Observatory.
50 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.